| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 125,864 | 62,622 | 47,702 | 77,346 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 125,864 | 62,622 | 47,702 | 77,346 | | | Operating Expenses | | Research Development |
-
|
-
| (132,799) | 44,718 | | Selling General and Administrative | 5,590 | 4,693 | (4,026) | 18,545 | | Non Recurring |
-
|
-
| 36,271 | 990 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 120,274 | 57,929 | 148,256 | 13,093 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,505 | 336 | 2,348 | 3,218 | | Earnings Before Interest And Taxes | 121,779 | 58,265 | 150,604 | 16,311 | | Interest Expense | 3,357 | 3,574 | 2,261 | 3,983 | | Income Before Tax | 118,422 | 54,691 | 148,343 | 12,328 | | Income Tax Expense | 41,185 | 17,234 | 35 | 2,612 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 77,237 | 37,457 | 148,308 | 9,716 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| (107,669) | 45,975 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 77,237 | 37,457 | 40,639 | 55,691 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $77,237 | $37,457 | $40,639 | $55,691 |
|
1.48% Nasdaq 
Income Statement
